Identification of Metabolites of Ganoderic Acid D by Ultra-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry
文献类型:期刊论文
作者 | Cheng, Chunru2; Yang, Min2; Yu, Kate1; Guan, Shuhong2![]() ![]() |
刊名 | DRUG METABOLISM AND DISPOSITION
![]() |
出版日期 | 2012-12 |
卷号 | 40期号:12页码:2307-2314 |
ISSN号 | 0090-9556 |
DOI | 10.1124/dmd.112.047506 |
文献子类 | Article |
英文摘要 | Ganoderic acid D (GD) is the major active triterpenoid in Ganoderma lucidum, a medicinal fungus used daily. However, the metabolic fate of GD remains unknown. To know whether GD is extensively metabolized, we first investigated the metabolism of GD in vitro and in vivo. The metabolic profiles of the bile samples obtained from rats in vivo were almost the same as those obtained in vitro. Using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry, a total of 25 metabolites were identified from the bile sample. Few metabolites were found in the urine samples. These results indicated that biliary rather than renal clearance was the major route of excretion. The major metabolites were identified by comparison with the standard reference compounds. Metabolites at low concentrations were identified by interpreting the mass spectra. Both phase I and phase II metabolites were observed. The metabolic transformation included reduction, monohydroxylation, dihydroxylation, trihydroxylation, oxidation, desaturation, sulfation, and glucuronidation. The main metabolic soft spots in the chemical structure of GD were the 3-carbonyl group, angular methyl groups, the 7-hydroxy group, and the 26-carboxylic acid moiety. Overall, this study gives us an insight into the metabolism of GD, an active oxygenated tetracyclic triterpenoid. |
WOS关键词 | LUCIDUM ; TRITERPENOIDS ; PRODUCTS |
资助项目 | National Natural Science Foundation of China[30701077] ; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program," China[2009ZX09308-005] ; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program," China[2009ZX09311-001] ; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program," China[2009ZX09502-020] ; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program," China[2009ZX09304-002] ; Chinese Academy of Sciences[KSCX2-YW-R-166] |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
WOS记录号 | WOS:000311106300011 |
出版者 | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS |
源URL | [http://119.78.100.183/handle/2S10ELR8/277866] ![]() |
专题 | 上海中药现代化研究中心 |
通讯作者 | Guo, Dean |
作者单位 | 1.Waters Corp, Milford, MA USA; 2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Res Ctr Modernizat Tradit Chinese Med, Natl Engn Lab TCM Standardizat Technol,Shanghai I, Shanghai 201203, Peoples R China; 3.Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, Decatur, GA 30033 USA; 4.Vet Affairs Med Ctr, Decatur, GA 30033 USA |
推荐引用方式 GB/T 7714 | Cheng, Chunru,Yang, Min,Yu, Kate,et al. Identification of Metabolites of Ganoderic Acid D by Ultra-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry[J]. DRUG METABOLISM AND DISPOSITION,2012,40(12):2307-2314. |
APA | Cheng, Chunru.,Yang, Min.,Yu, Kate.,Guan, Shuhong.,Tao, Sijia.,...&Guo, Dean.(2012).Identification of Metabolites of Ganoderic Acid D by Ultra-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry.DRUG METABOLISM AND DISPOSITION,40(12),2307-2314. |
MLA | Cheng, Chunru,et al."Identification of Metabolites of Ganoderic Acid D by Ultra-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry".DRUG METABOLISM AND DISPOSITION 40.12(2012):2307-2314. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。